Skip to content
‹ Back to IndustriesHealthcare

Can Drones Make a Difference During the COVID-19 Pandemic?

With social distancing in effect to counteract the COVID-19 pandemic, many companies and groups are seeking ways to respond to needs without making human contact. Drones may be an answer. Ken Stewart, CEO of AiRXOS, GE Aviation, as well as Chris Todd, Executive Director, Airborne International Response Team, and Charles Warner, Director, Drone Responders…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Can Drones Make a Difference During the COVID-19 Pandemic?

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

With social distancing in effect to counteract the COVID-19 pandemic, many companies and groups are seeking ways to respond to needs without making human contact. Drones may be an answer. Ken Stewart, CEO of AiRXOS, GE Aviation, as well as Chris Todd, Executive Director, Airborne International Response Team, and Charles Warner, Director, Drone Responders Public Safety Alliance, joined in this episode of Drones in America with Grant Guillot to discuss the prospect.

Stewart referenced the recent mission of a Blackhawk to bring supplies and virus testing kits to a cruise ship in California. “A crew of at least 3 could potentially get exposed,” he said. With drones, he added “you could control exposure to the contaminant.” On top of this, there could be significant cost savings in deploying drones instead. Drones fit into public health and relief efforts because they are effective for “limiting human to human interactions, which is really important,” explained Todd.

Despite these benefits of using drones in response to issues like COVID-19, there are also many challenges. Warner pointed out that one challenge is finding ways for companies and organizations to “limit their exposure while maintaining their service.” As drones are new technologies, and emergencies are not the time for testing, exploratory missions and reviews are what is current in this field.

Experts in the drone industry are launching task forces and exploring “the realistic possibilities without interfering with operations happening today,” Warner said. For example, delivery of medications or the use of drones to see what’s happening in areas that dispatch has been called to are viable applications being considered.

Overall, the goal of drone organizations at this time is not to explore and deploy solutions to advance the industry, but to find ways to meet very real and pressing needs. Tune in to learn more.

Catch up on previous episodes right here!

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512